'Alveolar soft part sarcoma' diaporamas de présentation

SOFT TISSUE TUMORS

1.04k views • 91 slides

Phase II Study of Dasatinib (BMS-354825) in Advanced Sarcomas and Chordoma

Phase II Study of Dasatinib (BMS-354825) in Advanced Sarcomas and Chordoma. Coordinating Center: U Michigan. Probability of response to imatinib (95% posterior credible intervals). Rationale for trial: extension of results from imatinib in sarcoma.

338 views • 18 slides

Priority of SARC studies for selected sub-types

Priority of SARC studies for selected sub-types. SARC 003 Gem/docetaxel Osteo/Ewings < 2 prior regimens Chondrosarcoma 0-X prior regimens SARC 006 AI/IE 1 st line. SARC 007 Perifosine < 3 prior regimens SARC009 Dasatinib 0-X prior regimens SARC 011 R1507 0-X prior regimens.

244 views • 9 slides